<DOC>
	<DOCNO>NCT02717572</DOCNO>
	<brief_summary>In current study , investigator plan expand knowledge Positron Emission Tomography/Magnetic Resonance ( PET/MR ) reliability assess repeatability fludeoxyglucose ( FDG ) standardize uptake value ( SUV ) measurement , well apparent diffusion coefficient ( ADC ) measurement , broad population patient malignant solid tumor .</brief_summary>
	<brief_title>18F-FDG Uptake Measurements Malignant Solid Tumors PET/CT PET/MR</brief_title>
	<detailed_description />
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>Patients histologically confirm malignant solid tumor ( local metastatic , newly diagnose recurrent disease ) . Patient must least one lesion measure â‰¥ 2.0 cm . 18 year age old . Ability provide inform consent . Cancer therapy within 30 day baseline imaging . Uncontrolled intercurrent illness include , limited active infection . Patients insulindependent diabetes . Patients metal device body include , limited metallic joint prosthesis , artificial heart valve , pacemaker , cochlear implant . Patients pregnant nursing . Inability tolerate 60 minute PET image . Inability comply study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>